Feedback / Questions
ARKD-104 - Arkuda Therap
https://www.prnewswire.com/news-releases/arkuda-therapeutics-to-present-update-on-arkd-104-its-first-in-class-oral-development-candidate-for-the-treatment-of-frontotemporal-dementia-and-other-neurodegenerative-disorders-at-the-alzheimers-association-international-confe-301879066.html
Jul 18, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next